imidocarb

Also known as N,N'-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea, 1,3-bis(3-(2-imidazolin-2-yl)phenyl)urea

Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites.

Research

350 papers

Antiprotozoal treatment of canine babesiosis.Veterinary parasitology · 2018
Residue Depletion of Imidocarb in Bovine Tissues by UPLC-MS/MS.Animals : an open access journal from MDPI · 2022
Diminazene aceturate and imidocarb dipropionate-based combination therapy for babesiosis - A new paradigm.Ticks and tick-borne diseases · 2023
Pharmacokinetics of imidocarb dipropionate in white-tailed deer (Odocoileus virginianus) after single intramuscular administration.Journal of veterinary pharmacology and therapeutics · 2020
Pharmacokinetics and bioequivalence of two imidocarb formulations in cattle after subcutaneous injection.PloS one · 2022

via PubMed

Wikidata facts

Mass: 348.17

Show 3 more facts

chemical formula: C₁₉H₂₀N₆O
canonical SMILES: C1CN=C(N1)C2=CC(=CC=C2)NC(=O)NC3=CC=CC(=C3)C4=NCCN4
World Health Organisation international non-proprietary name: imidocarb

Sources (2)

via Wikidata · CC0

~1 min read

Article

2 sections

Contents

Mechanism of action
References

Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites.

==Mechanism of action== Imidocarb is anticholinergic; it inhibits acetylcholinesterase.